This study demonstrated that SHD-RT effectively enhanced tumor perfusion (Figure 4D) and improved the effective delivery of anti-PD-L1 antibody (Figure 6B) in this preclinical pancreatic tumor model. Here, CD274 is linked to neoplasm.